Learn about the global AI In pharma market through The Business Research Company, which provides information on AI In pharma market size, AI In pharma market drivers and restraints, AI In pharma market players, the COVID-19 impact on the AI In pharma market, and more.

The global AI in pharma market size is expected to grow from $934.56 million in 2021 to $1,236.09 million in 2022 at a compound annual growth rate (CAGR) of 32.3%. The change in the AI in pharma market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2021. The market is expected to reach $3626.24 million in 2026 at a CAGR of 30.9%.

The growing adoption of artificial intelligence (AI) for clinical trials research is driving its demand for AI in pharma market.

Request A Sample For The Global AI In Pharma Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3887&type=smp

The AI in pharma market consists of sales of AI in the pharma and related services that use an automated algorithm to perform tasks that traditionally rely on human intelligence. It can be useful in handling data and presenting results that encourage better decision-making and save human efforts, cost, and time. The market consists of revenue generated by artificial intelligence companies, which are applying in the pharmaceutical industry. Only goods and services traded between entities or sold to end consumers are included.

Global AI In Pharma Market Segments Include:

By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning

By Drug Type: Small Molecule, Large Molecules

By Application: Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the artificial intelligence in pharma market in 2021.

Companies operating in the AI for the pharma market are introducing new AI tools that will be beneficial for the pharma companies and this is a key trend in AI in pharma market. AI helps in quality control, predictive maintenance, waste reduction, design optimization and process automation.

TBRC’s AI In pharma market report covers:

Major Market Players: Novartis, IBM Watson, Microsoft Corporation, Merck, GNS Healthcare., Google, AstraZeneca, Atomwise Inc., Exscientia, Cyclica, NVIDIA Corporation, XtalPi Inc., BenevolentAI, Cloud Pharmaceuticals Inc, BERG LLC, Bayer, Pfizer, Recursion Pharmaceuticals Inc., and Bristol-Myers Squibb.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The AI In Pharma Global Market Report 2022 –Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides AI In pharma market overviews, analyzes and forecasts market size, share, AI In pharma market players, AI In pharma market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s AI In pharma market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022

Artificial Intelligence Services Global Market Report 2022

Artificial Intelligence Global Market Report 2022

Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: